DIEBOLD INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Automated_Intelligence_Report :: DBD
Algorithmic analysis of recent insider trading activity for DBD reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 17 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $139.04M.
Market dynamics show a negative net capital flow of $130.59M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the landscape is fragmented. Baur Frank Tobias led the buying pressure, while Millstreet Capital Management LLC registered the largest single offload of shares. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of DBD.
$139.04M
USD NOMINAL VALUE17
UNIQUE C-SUITE ENTITIES2026.05.27
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>Who is currently buying DBD stock?
Based on the latest SEC Form 4 filings, Baur Frank Tobias (Officer/Other) has been actively acquiring shares. The total recent insider buying volume stands at $1.04M.
>Are DBD insiders selling their shares?
Yes, we have tracked $131.63M in recent insider liquidations. The most notable recent seller is Millstreet Capital Management LLC, who executed the largest single offload.
>What is the overall insider sentiment for DBD?
The short-term structural capital flow indicates a BEARISH sentiment, with a net flow of $130.59M generated by 17 active C-Suite entities.